BioSpace News Archive

Vektor Medical, Inc., a private company founded to develop the next-generation in arrhythmia mapping systems, today announced the publication of results of a dual-site study involving its non-invasive vMap™ system during stereotactic ablative radiotherapy (SAbR), in the peer-reviewed journal, Heart Rhythm O2.

Midwest Products & Engineering (MPE-INC), a leading design and contract manufacturer of medical devices, today announced its acquisition of MindFlow Design, a Southern California leading medical product design firm offering concept through manufacture-ready product specifications with a proven three-phase proprietary design process.

Moderna, Inc today announced significant advances across its portfolio of mRNA pipeline programs being presented at the Company’s fifth annual R&D Day today.

InflaRx will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference, which is being held virtually.

Repligen Corporation and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies and Fc-fusion proteins.

KemPharm, Inc.today announced that Travis C. Mickle, Ph.D., President and Chief Executive Officer of KemPharm, will present virtually at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.

Rapid Micro Biosystems, Inc. today announced that it is set to join the Russell 2000®, Russell 3000® and Russell Microcap® indexes, effective after the U.S. market opens on September 20, 2021

Mereo BioPharma Group plc today announced senior management’s participation in three upcoming investor conferences: Morgan Stanley 19th Annual Global Healthcare Conference 1x1 meetings, September 13 – 14, 2021

Amolyt Pharma and PeptiDream Inc. announced that Amolyt Pharma has exercised its option to globally license a portfolio of macrocyclic peptide growth hormone receptor antagonists under the terms of its research collaboration agreement with PeptiDream announced in December 2020.

Agenus today announced that Jennifer Buell, PhD, President and COO of Agenus, will participate in the following upcoming conferences: H.C. Wainwright 23rd Annual Global Investment Conference